Michael K Hardy, MD, MPH in Orem, UT - Preventive Medicine

Michael K Hardy, MD, MPH is a Preventive Medicine - Occupational Medicine physician based in Orem, Utah. Michael K Hardy is licensed to practice in Utah (license number 188346-1205) and his current practice location is 601 N 1200 W, Orem, Utah. He can be reached at his office (for appointments etc.) via phone at (801) 224-4211.

NPI number for Michael K Hardy is 1144351198 and his current mailing address is 2390 S Redwood Rd, Salt Lake City, Utah. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1144351198.

Contact Information

	Michael K Hardy, MD, MPH
	601 N 1200 W, Orem, UT 84057-3522
	(801) 224-4211
	Not Available

Physician's Profile

Full Name	Michael K Hardy
Gender	Male
Speciality	Preventive Medicine - Occupational Medicine
Location	601 N 1200 W, Orem, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1144351198
Provider Enumeration Date: 03/08/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Michael K Hardy such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1144351198	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2083X0100X	Preventive Medicine - Occupational Medicine	188346-1205 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael K Hardy is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michael K Hardy, MD, MPH 2390 S Redwood Rd, Salt Lake City, UT 84119-2027 Ph: (801) 975-1600	Michael K Hardy, MD, MPH 601 N 1200 W, Orem, UT 84057-3522 Ph: (801) 224-4211

News Archive

NYC public health officials launch new program to locate lost to follow-up patients with HIV

Public health officials in New York City have launched a successful program to locate HIV-positive patients who have been "lost to follow-up" and reconnect them with treatment services, reports a study published in AIDS, official journal of the International AIDS Society.

Following the withdrawal of Vioxx, the European Medicines Agency has been asked to review of COX-2 inhibitor medicines

Following the worldwide withdrawal of Vioxx (rofecoxib), the European Medicines Agency (EMEA) has been asked by the European Commission, as a precautionary measure, to conduct a review of COX-2 inhibitor medicines.

Insurers defend less generous policies, medical loss ratio definitions; Obama to talk with insurance commissioners

Kaiser Health News, in collaboration with USA Today, reports on insurers who are defending less generous "limited-benefit" health policies as implementation of the health law proceeds. That law forbids annual dollar limits in such plans. "Starting this fall, most health care policies — except existing policies purchased by individuals on their own — will have to cover at least $750,000 in medical care per person.

Living near a busy road may increase dementia risk, study reports

People living within 50 meters of a busy road are at an increased risk of developing dementia, compared with people who live further away, according to research published in The Lancet.The study also analyzed the link between traffic pollution exposure and the risk of Parkinson's disease...

FDA's decision on Avastin will take away choice for many patients, says Breastcancer.org

Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist in the Philadelphia area submitted a letter to the U.S. Food and Drug Administration prior to the Oncology Drug Advisory Committee (ODAC) meeting to review data for Avastin's use in metastatic HER2-negative breast cancer. In light of today's news that the FDA has recommended removing Avastin's approval to treat breast cancer, Breastcancer.org is making public Dr. Weiss' ODAC letter in its entirety.

Preventive Medicine Doctors in Orem, UT

Thomas Lee Schumann, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 331 N 400 W, Orem, UT 84057 Phone: 801-714-3205
Jason L Andersen, DO Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1215 S 1680 W, Orem, UT 84058 Phone: 385-277-0900 Fax: 801-465-3267

Michael K Hardy, MD, MPH - Preventive Medicine in Orem, UT